Evaluation of the Biological Activity of Human Growth Hormone by Enzyme Linked Immuno-Receptor Assay (ELIRA) Method

REFERENCES

• Adrian, C. H., Noelle, V., Henry, G. B. (1976). Characterization of the binding of human growth hormone to microsomal membrane from rat liver. Biochem. J. 158:61–69.
   PubMedGoogle Scholar
• Ashkenazi, A., Cohen, R., Certler, A. (1987). Characterization of lactogenic receptors in lactogenic hormone-dependent and independent NB2 lymphoma cell lines. FEBS Lett. 210:51–55.
   PubMedGoogle Scholar
• Baneyx, F., Mujacic, M. (2004). Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol. 22:1399–1408.
   PubMed Web of Science ®Google Scholar
• Boge, A., Sauerwein, H., Meyer, H. H. (1994). An enzyme immunoreceptor assay for the quantitation of insulin-like growth factor-I and insulin receptors in bovine muscle tissue. Anal. Biochem. 216:406–412.
   PubMedGoogle Scholar
• Brian, C. C., James, A. W. (1989). High-resolution epitope mapping of hGh-receptor interaction by alanin-scanning mutagenesis. Science 244:1081–1085.
   PubMedGoogle Scholar
• Cynthia, G. G., Rilene M. O. F., Stephanie, K., Lilia De, S. L., Jennifer, A. M., George Z. (2001). Characterization of the growth hormone receptor in human dermal fibroblasts and liver during development. Am. J. Physiol. Endocrinol. Metab. 281:1213–1220.
   Google Scholar
• David, W. L., Steven, A. S., George, C., Hammonds, G., Collins, C., William, J. H., Ross B., Michael, J. W., William, I. W. (1987). Growth hormone receptor and serum binding protein: Purification, cloning and expression. Nature 330:537–543.
   PubMedGoogle Scholar
• Deckert, F., Legay, F. (1999). Development and validation of an immunoreceptor assay for simulect based on surface plasmon resonance. Anal. Biochem. 274:81–89.
   PubMed Web of Science ®Google Scholar
• Di Marco, S., Fendrich, G., Meyhack, B., Grutter, M. G., 1996. Refolding, isolation and characterization of crystallizable human interferon-alpha and expression in Saccharomyces cerevisiae. J. Biotechnol. 50:63–73.
   PubMedGoogle Scholar
• Frank, S. J., Messina, J. L., Baumann, G., Black, R. A., Berties, P. J. (2000). Insights into modulation of (and by) growth hormone signaling. J. Lab. Clin. Med. 136: 14–20.
   PubMedGoogle Scholar
• Gregory, L. B., Richard, H. (1997). Iodination of chemokines for use in receptor binding analysis. Meth. Enzymol. 288:134–158.
   PubMedGoogle Scholar
• Gurvey, S. J., Cremer, N. E., Sussdrof, D. H. (1977). Prepration of antiserum. In: Methods in Immunology, London: W.A. Benjamin Inc.;194–210.
   Google Scholar
• Harlow, E., Lane, D. (1988). Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
   Google Scholar
• Hocqutte, J. F., Postel-Vinay, M. C., Kayser, C., De Hemptinne, B., Amar-Costeses, A. (1989). The human liver growth hormone receptors. Endocrinology 125:2167–2174.
   PubMedGoogle Scholar
• Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., Binoux, M. (1986). Analysis of serum insulin-like growth factor binding proteins using western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154:138–143.
   PubMed Web of Science ®Google Scholar
• James, P. H., Toshiaki, T., Peter, W. G., Charles, T. B., Robert L. N., Henry, G. F. (1982). Effect of iodination on human growth hormone and prolactin: Characterization by bioassay. RadioImmunoassay Radio receptor assay and Electrophoresis. Endocrinology 111:827–832.
   PubMedGoogle Scholar
• Jesse, R. (1976). Radio receptor assay of human growth hormone. Meth. Enzymol. 37:70–81.
   Google Scholar
• Katsuhiro, O., Masanobu, N., Michio, M. (1987). Immunochemical studies of microsomal membranes of rat preneoplastic and neoplastic hepatocytes. Toxicol. Pathol. 15(1):69–72.
   PubMedGoogle Scholar
• Laemmeli, U. K. (1970). Cleavage of structural proteins during the head of bacteriophage T4. Nature 227:680–685.
   PubMed Web of Science ®Google Scholar
• Laron, Z., Bidlingmaier, M., Strasburger, C. J. (2007). Indications, limitations and pitfalls in the determination of human growth hormone, IGF-I and their binding proteins. Pediatr. Endocrinol. Rev. 5:555–569.
   PubMedGoogle Scholar
• Masao, K., Sally, R., Joseph, Z., Jean, D. (1987). Hepatic prolactin receptors in the rat: Characterization using monoclonal anti-receptor antibodies. Endocrinology 120:739–748.
   PubMedGoogle Scholar
• Mockridge, J. W., Aston, R., Morrell, D. J., Holder, A. T. (1998). Cross-linked growth hormone dimers have enhanced biological activity. Eur. J. Endocrinol. 138:449–459.
   PubMedGoogle Scholar
• Pagani, S., Chaler, E. A., Radetti, G., Travaglino, P., Meazza, C., Bozzola, E., Sessa, N., Belgorosky, A., Bozzola, M. (2007). Variations in biological and immunological activity of growth hormone during the neonatal period. Horm. Res. 68:145–149.
   PubMedGoogle Scholar
• Pearce, K., Wells J. A. (1998). Activation of the human growth hormone receptor: structure and function of the ligand-receptor complex. In: Human Growth Hormone: Basic and Clinical Research, editors, Smith RG, Throner MO. Totowa, NJ: Humana; P. 131–143.
   Google Scholar
• Petkovic, V., Besson, A., Thevis, M., Lochmatter, D., Eblé, A., Flück, C.E., Mullis, P. E. (2007). Evaluation of the biological activity of a growth hormone (GH) mutant (R77C) and its impact on GH responsiveness and stature. J. Clin. Endocrinol. Metab. 92:893–901.
   Google Scholar
• Preobrazhensky, S. N., Ivanov, V. O., Fuki, I. V., Tsibulsky, V. P., Kameneva, A. M., Repin, V. S., Ermolin, G. A. (1985). Enzyme-linked immunoreceptor assay of low-density-lipoprotein receptors. Anal. Biochem. 149:269–274.
   PubMedGoogle Scholar
• Rabindran, S., Stevenson, N., Roy, G., Fedorkin, O., Skarjinskaia, M., Ensley, B., Yusibov, V. (2009). Plant-produced human growth hormone shows biological activity in a rat model. Biotechnol. Prog. 25:530–834.
   PubMedGoogle Scholar
• Ranke, M. B. (2008). New preparations comprising recombinant human growth hormone: deliberations on the issue of biosimilars. Horm. Res. 69:22–28.
   PubMed Web of Science ®Google Scholar
• Robert, E. C., Seth, Guller., Kai-Yuan, W., Martin, S. (1990). Growth hormone and adipose differentiation: Growth hormone-induced antimiogenic state in 3T3-F442A preadipose cells. Proc. Natl. Acad. Sci. 87:7507–7511.
   PubMedGoogle Scholar
• Schmidt, F. R. (2004). Recombinant expression system in the pharmaceutical industry. Appl. Microbiol. Biotechnol. 65:363–372.
   PubMed Web of Science ®Google Scholar
• Sitta S. G., Wendell, C. S., Thomas W. M., David, R. S., Clyde, M. (1996). Application of experimental design techniques to optimize a competitive ELISA. J. Immunol. Meth. 190:151–161.
   PubMedGoogle Scholar
• Smal, J., Closset, J., Hennen, G., DeMeyts, P. 1985. Receptor-binding and down-regulatory properties of 22000-Mr human growth hormone and its natural 20000-Mr variant on IM-9 human lymphocytes. Biochem. J. 225:283–289.
   PubMedGoogle Scholar
• Tolbert, W. R., Rupp, R. G. (1989). Manufacture of pharmaceutical proteins from hybridomas and other cell substrates. Dev. Biol. Stand. 70:49–56.
   PubMedGoogle Scholar
• Tsushima, T., Friesen, H. G. (1973). Radio receptor assay for growth hormone. J. Clin. Endocrinol. Metab. 37:334–337.
   PubMed Web of Science ®Google Scholar
• Webb, C. F., Cadman, H. F., Wallis, M. (1986). The specificity of binding of growth hormone and prolactin to purified plasma membranes from pregnant-rabbit liver. Biochem. J. 236:657–663.
   PubMedGoogle Scholar
• Wendler, J., Hoffmann, A., Gross, G., Weich, H. A., Bilitewski, U. (2005). Development of an enzyme-linked immunoreceptor assay (ELIRA) for quantification of the biological activity of recombinant human bone morphogenetic protein-2. J. Biotechnol. 119:425–435.
   PubMedGoogle Scholar
• Zor, T., Selinger, Z. (1996). Linearization of the Bradford protein assay increases its sensitivity: Theoretical and experimental studies. Anal. Biochem. 236:302–308.
   PubMed Web of Science ®Google Scholar